For many cancer patients, clinical trials are a new opportunity for treatment, especially in cases where various therapies have been…
UITM-CaixaResearch
Advances driven by research have led to significant developments in better understanding the molecular taxonomy of cancer and therapeutic breakthroughs…
Presented today at the ESMO Congress 2024* by Maria Vieito, Medical Oncologist at the Vall d’Hebron University Hospital, CORE Phase…
Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that it is a drug with…
Coinciding with the celebration on May 20 of the Clinical Trials World Day, this Monday the fifth chapter of the…